Pembrolizumab in Combination With CRT for LA-SCCHN
Phase 1 Completed
59 enrolled 9 charts
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Phase 1 Completed
41 enrolled
DEPEND
Phase 2 Completed
35 enrolled 14 charts
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Phase 1 Completed
13 enrolled
IMMUNEBOOST
Phase 2 Completed
62 enrolled
OPTIMA
Phase 2 Completed
62 enrolled 13 charts
Addition of Aspirin to Standard of Care in Oral Cancer
Phase 2/3 Completed
60 enrolled
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Phase 1 Completed
48 enrolled
HNCs
Completed
150 enrolled
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
Phase 2 Completed
32 enrolled
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Phase 3 Completed
111 enrolled 11 charts
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
Phase 2 Completed
30 enrolled 26 charts
PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma
Completed
104 enrolled
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Completed
186 enrolled
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
Phase 1 Completed
24 enrolled
Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)
Phase 2 Completed
43 enrolled 11 charts
SUSPECT
Phase NA Completed
61 enrolled
Randomized Amifostine For SCCHN
Phase 2 Completed
58 enrolled
Open Label, Phase I ZD6474 Head and Neck Cancer Study
Phase 1 Completed
48 enrolled
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
Phase 2 Completed
42 enrolled
DeLOS II
Phase 2 Completed
180 enrolled
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 1 Completed
30 enrolled
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Phase 1 Completed
39 enrolled